Clinical proteomics: A novel diagnostic tool for the new biology of preterm labor, part I: Proteomics tools

Obstetrical and Gynecological Survey

Volumn 61, Issue 7, 2006, Pages 481-486

  Buhimschi, Catalin S ^a   Weiner, Carl P ^b   Buhimschi, Irina A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT;

CHILDBIRTH; DIAGNOSTIC PROCEDURE; FEMALE; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; HUMAN GENOME; MASS SPECTROMETRY; MICROARRAY ANALYSIS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PROTEOMICS; REVIEW; TECHNOLOGY; UTERUS CONTRACTILITY;

BIOLOGICAL MARKERS; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; OBSTETRICS; PEPTIDE MAPPING; PREGNANCY; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 33745652101     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ogx.0000224617.11789.ab     Document Type: Review

References (30)

1. Stoll BJ, Hansen NI, Adams-Chapman I, et al. National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357-2365.
2. Hamilton BE, Martin JA, Sutton PD. Births: preliminary data for 2003. Natl Vital Stat Rep November 23, 2004;53(9).
3. Shankar R, Gude N, Cullinane F, et al. An emerging role for comprehensive proteome analysis in human pregnancy research. Reproduction 2005;129:685-696.
4. Lieber CD. Introduction to Proteomics. Tools for the New Biology. Totowa, NJ: Humana Press Inc, 2002.
5. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-1351.
6. Banks RE, Dunn MJ, Hochstrasser DF, et al. Proteomics: new perspectives, new biomedical opportunities. Lancet 2000;356:1749-1756.
7. Zenclussen AC, Zenclussen ML, Ritter T, et al. The use of gene therapy tools in reproductive immunology research. Curr Gene Ther 2005;5:459-466.
8. Farag K, Hassan I, Ledger WL. Prediction of preeclampsia: can it be achieved? Obstet Gynecol Surv 2004;59:464-482.
9. Park KH, Yoon BH, Shim SS, et al. Amniotic fluid tumor necrosis factor-alpha is a marker for the prediction of early-onset neonatal sepsis in preterm labor. Gynecol Obstet Invest 2004;58:84-90.
10. Lockwood CJ, Krikun G, Schatz F. Decidual cell-expressed tissue factor maintains hemostasis in human endometrium. Ann N Y Acad Sci 2001;943:77-88.
11. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18:533-537.
12. Monti M, Orru S, Pagnozzi D, et al. Interaction proteomics. Biosci Rep 2005;25:45-56.
13. Wiederkehr F, Vonderschmitt DJ. [2-dimensional electrophoresis of cerebrospinal fluid in various neurological patients.] Schweiz Med Wochenschr 1985;115:368-373.
14. Chen JH, Chang YW, Yao CW, et al. Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci U S A 2004;101:17039-17044.
15. Fung KY, Glode LM, Green S, et al. A comprehensive characterization of the peptide and protein constituents of human seminal fluid. Prostate 2004;61:171-181.
16. Vuadens F, Benay C, Crettaz D, et al. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 2003;3:1521-1525.
17. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997;18:2071-2077.
18. Patterson SD, Aebersold R. Mass spectrometric approaches for the identification of gel-separated proteins. Electrophoresis 1995;16:1791-1814.
19. Gygi SP, Aebersold R. Mass spectrometry and proteomics. Curr Opin Chem Biol 2000;4:489-494.
20. Yates JR 3rd. Mass spectrometry. From genomics to proteomics. Trends Genet 2000;16:5-8.
21. Kuwata H, Yip TT, Yip CL, et al. Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferrin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Commun 1998;245:764-773.
22. Fung ET, Yip TT, Lomas L, et al. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int J Cancer 2005;115:783-789.
23. Hermjakob H, Apweiler R. The Proteomics Identifications Database (PRIDE) and the ProteomExchange Consortium: making proteomics data accessible. Expert Rev Proteomics 2006;3:1-3.
24. Lo SL, You T, Lin Q, et al. SPLASH: systematic proteomics laboratory analysis and storage hub. Proteomics 2006;6:1758-1769.
25. Hochstrasser DF. Proteome in perspective. Clin Chem Lab Med 1998;36:825-836.
26. Neubauer G, Gottschalk A, Fabrizio P, et al. Identification of the proteins of the yeast U1 small nuclear ribonucleoprotein complex by mass spectrometry. Proc Natl Acad Sci U S A 1997;94:385-390.
27. Petricoin EF, Ardekani AM, Hitt BA. Use of proteomic pattern in serum to identify ovarian cancer. Lancet 2002;359:572-527.
28. Papadopoulos MC, Abel PM, Agranoff D, et al. A novel and accurate diagnostic test for human African trypanosomiasis. Lancet 2004;363:1358-1363.
29. Pucci-Minafra I, Fontana S, Cancemi P, et al. Proteomic patterns of cultured breast cancer cells and epithelial mammary cells. Ann N Y Acad Sci 2002;963:122-139.
30. Meehan KL, Holland JW, Dawkins HJ. Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer. Prostate 2002;50:54-63.